Cite
MLA Citation
Tamer Khashab et al.. “Long‐term overall‐ and progression‐free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non‐Hodgkin lymphoma.” British journal of haematology, vol. 185, 2019, pp. 670–678. http://access.bl.uk/ark:/81055/vdc_100081485775.0x000061